Some HER2-Negative Cancers May Benefit from Anti-HER2 Therapy

SAN ANTONIO (IMNG) - Some breast cancers categorized as HER2 negative by conventional testing harbor mutations that may still render them amenable to therapy targeting this receptor, researchers reported...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news